×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

InsideArbitrage Potential Deal Alert: Taro Pharmaceutical Industries (TARO) approached by Sun Pharmaceutical

  • May 27, 2023

POTENTIAL DEAL DETAILS

Stock Taro Pharmaceutical Industries Symbol TARO
Date Announced 05/26/2023 Source Press Release
Type Unsolicited Bid Acquiring Company/Person Sun Pharmaceutical Industries
Date of Confirmation: 01/17/2024 Price at Confirmation: $41.28
Potential Profit: 14.35% Annualized Profit: 22.19%

Taro Pharmaceutical Industries (TARO) received a non-binding offer from its majority shareholder Sun Pharmaceutical to acquire shares, it doesn’t already own for $38 per share in cash.

Update(s):

December 11, 2023: Sun Pharmaceutical updated its offer price to $43 per share to acquire all the outstanding shares of Taro Pharma.  On December 10, 2023, the Special Committee confirmed that it agreed in principle with the Revised Proposal and that it has agreed to negotiate definitive agreements.

 

 

Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.